Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 7/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CRHBP | P24387 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.38 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18563297 | 1.00 | AHR (0.47) | AHRALDH1A1L3MBTL1TDP1KDM4E | |
| SCHEMBL22180111 | 0.98 | ALDH1A1 (0.46) | AHRALDH1A1L3MBTL1TDP1KDM4E | |
| SCHEMBL22825386 | 0.96 | AHR (0.44) | AHRALDH1A1L3MBTL1TDP1KDM4E | |
| SCHEMBL18563264 | 0.94 | AHR (0.52) | AHRALDH1A1L3MBTL1TDP1KDM4E | |
| SCHEMBL18563248 | 0.93 | AHR (0.41) | AHRALDH1A1L3MBTL1TDP1KDM4E | |
| SCHEMBL18563259 | 0.90 | AHR (0.42) | AHRALDH1A1L3MBTL1TDP1KDM4E | |
| SCHEMBL18563290 | 0.90 | AHR (0.42) | AHRALDH1A1L3MBTL1TDP1KDM4E | |
| SCHEMBL18563227 | 0.90 | AHR (0.42) | AHRALDH1A1L3MBTL1TDP1KDM4E | |
| SCHEMBL24277620 | 0.88 | KDM4E (0.43) | AHRALDH1A1L3MBTL1TDP1KDM4E | |
| SCHEMBL12259304 | 0.87 | ALDH1A1 (0.38) | AHRALDH1A1L3MBTL1TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10361373-B2 | Condensed-cyclic compound and organic light emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-07-23 | — | — | US | disclosed |
| US-20170062720-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-02 | — | — | US | disclosed |
| US-20170062720-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-02 | — | — | US | disclosed |
| EP-3135673-A2 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | Samsung Display Co., Ltd. (KR) | 2017-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170062720-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LRRK2, SLC18A1, CCNT1 | AHR 2829/4885ALDH1A1 832/4885L3MBTL1 377/4885 |
| US-10361373-B2 | Condensed-cyclic compound and organic light emitting device comprising the same | LRRK2, SLC18A1, CCNT1 | AHR 2829/4885ALDH1A1 832/4885L3MBTL1 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.